Responses
Clinical and epidemiological research
Extended report
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry
Compose a Response to This Article
Other responses
No responses have been published for this article.